Trending News
- Long-Term Risk of Malignancy in IPMNs
- Afferent Limb Syndrome Treated via Lumen Apposing Metal Stents: Report of Two Different Approaches in Two Patients
- Dupilumab in Treatment of Active Eosinophilic Esophagitis
- Collagenous Gastritis in a Patient with Eosinophilic Esophagitis
- Crohn’s Disease Complicated by an Intra-abdominal Abscess: Poke, Prod, or Cut?
- Long-Term Risk of Malignancy in IPMNs
- Afferent Limb Syndrome Treated via Lumen Apposing Metal Stents: Report of Two Different Approaches in Two Patients
- Dupilumab in Treatment of Active Eosinophilic Esophagitis
- Collagenous Gastritis in a Patient with Eosinophilic Esophagitis
- Crohn’s Disease Complicated by an Intra-abdominal Abscess: Poke, Prod, or Cut?
- Long-Term Risk of Malignancy in IPMNs
- Afferent Limb Syndrome Treated via Lumen Apposing Metal Stents: Report of Two Different Approaches in Two Patients
- Dupilumab in Treatment of Active Eosinophilic Esophagitis
- Collagenous Gastritis in a Patient with Eosinophilic Esophagitis
- Crohn’s Disease Complicated by an Intra-abdominal Abscess: Poke, Prod, or Cut?
- This event has passed.
17th World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease (WCIRDC)
December 5, 2019 - December 7, 2019
The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 17th year, is a unique and exciting multidisciplinary program. The Congress is the premiere global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease (CVD), and energy balance, linking basic research to clinical practice, and highlighting the theme: Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today.
Approved for AMA PRA Category 1 Credits™